WealthTrust-Arizona’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$68K Hold
1,308
0.04% 125
2018
Q3
$81K Hold
1,308
0.04% 117
2018
Q2
$72K Hold
1,308
0.04% 116
2018
Q1
$83K Sell
1,308
-342
-21% -$22K 0.04% 118
2017
Q4
$101K Sell
1,650
-300
-15% -$18.8K 0.05% 102
2017
Q3
$124K Hold
1,950
0.06% 85
2017
Q2
$109K Hold
1,950
0.06% 85
2017
Q1
$106K Hold
1,950
0.06% 86
2016
Q4
$114K Hold
1,950
0.07% 87
2016
Q3
$105K Hold
1,950
0.06% 91
2016
Q2
$143K Hold
1,950
0.09% 79
2016
Q1
$125K Hold
1,950
0.08% 79
2015
Q4
$134K Hold
1,950
0.08% 85
2015
Q3
$115K Buy
1,950
+300
+18% +$19K 0.07% 82
2015
Q2
$110K Sell
1,650
-600
-27% -$39.5K 0.07% 88
2015
Q1
$145K Buy
2,250
+200
+10% +$12.5K 0.09% 74
2014
Q4
$121K Buy
2,050
+400
+24% +$22.6K 0.1% 82
2014
Q3
$84K Hold
1,650
0.09% 112
2014
Q2
$80K Buy
1,650
+900
+120% +$44.4K 0.09% 124
2014
Q1
$39K Buy
750
+100
+15% +$5.32K 0.04% 191
2013
Q4
$35K Buy
+650
New +$33.1K 0.04% 189

Other funds holding BMY

WealthTrust-Arizona's BMY Position: Q4 2018 in Review

WealthTrust-Arizona held its Bristol-Myers Squibb (BMY) position steady in Q4 2018 at 1,308 shares worth $68K. The position accounts for 0.04% of the portfolio, ranked #125.

WealthTrust-Arizona first reported a position in BMY in Q4 2013 and has held it in 21 quarters since. The position peaked at $145K in Q1 2015. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • WealthTrust-Arizona held 1,308 shares of Bristol-Myers Squibb worth $68K as of Q4 2018.
  • WealthTrust-Arizona left its Bristol-Myers Squibb share count unchanged in Q4 2018.
  • Bristol-Myers Squibb made up 0.04% of WealthTrust-Arizona's portfolio in Q4 2018, its #125 holding.
  • WealthTrust-Arizona first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 21 quarters since.
  • WealthTrust-Arizona's Bristol-Myers Squibb position peaked at $145K in Q1 2015.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.